Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine (With Epinephrine) in BABA Endoscopic and Robotic Thyroidectomy
NCT02112370Phase 3Completed
- Sponsor
- Seoul National University Hospital
- Start
- May 2014
- Primary completion
- May 2016
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine hydrochloride liposomal suspension injection in thyroid neoplasm, goiter, sponsored by Seoul National University Hospital. Started May 2014; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
thyroid neoplasmgoiter
Beyond the preview
Go deeper on NCT02112370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02112370.